DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,467,703 | -31.0% | 58,314 | -33.2% | 0.12% | -26.4% |
| Q2 2023 | $20,966,400 | -14.8% | 87,360 | -10.5% | 0.16% | -14.5% |
| Q1 2023 | $24,594,063 | -17.5% | 97,580 | -13.1% | 0.19% | -19.8% |
| Q4 2022 | $29,814,629 | -12.7% | 112,330 | -15.0% | 0.23% | -17.4% |
| Q3 2022 | $34,141,000 | +1.1% | 132,180 | -0.8% | 0.28% | +8.5% |
| Q2 2022 | $33,777,000 | -20.7% | 133,233 | -8.2% | 0.26% | -7.5% |
| Q1 2022 | $42,571,000 | -10.4% | 145,131 | +0.4% | 0.28% | -6.7% |
| Q4 2021 | $47,536,000 | +45.6% | 144,483 | +34.8% | 0.30% | +38.9% |
| Q3 2021 | $32,642,000 | +6.6% | 107,220 | -6.0% | 0.22% | +10.8% |
| Q2 2021 | $30,607,000 | +21.5% | 114,053 | +1.9% | 0.20% | +15.4% |
| Q1 2021 | $25,197,000 | -11.5% | 111,948 | -12.7% | 0.17% | -16.7% |
| Q4 2020 | $28,481,000 | +2.3% | 128,210 | -0.8% | 0.20% | -6.5% |
| Q3 2020 | $27,834,000 | +21.8% | 129,260 | 0.0% | 0.22% | +16.7% |
| Q2 2020 | $22,857,000 | +59.5% | 129,260 | +24.8% | 0.19% | +45.3% |
| Q1 2020 | $14,334,000 | -13.3% | 103,560 | -3.8% | 0.13% | +19.6% |
| Q4 2019 | $16,529,000 | +27.2% | 107,695 | +19.7% | 0.11% | +24.4% |
| Q3 2019 | $12,999,000 | +1.0% | 90,005 | 0.0% | 0.09% | +3.6% |
| Q2 2019 | $12,864,000 | +7.8% | 90,005 | -0.4% | 0.08% | +10.7% |
| Q1 2019 | $11,928,000 | +27.9% | 90,351 | -0.1% | 0.08% | +17.2% |
| Q4 2018 | $9,325,000 | -5.1% | 90,426 | +0.0% | 0.06% | +14.3% |
| Q3 2018 | $9,823,000 | +12.4% | 90,401 | +2.1% | 0.06% | +7.7% |
| Q2 2018 | $8,738,000 | +17.0% | 88,551 | +16.1% | 0.05% | +15.6% |
| Q1 2018 | $7,466,000 | +5.5% | 76,251 | 0.0% | 0.04% | +9.8% |
| Q4 2017 | $7,078,000 | +8.2% | 76,251 | 0.0% | 0.04% | +10.8% |
| Q3 2017 | $6,541,000 | +1.6% | 76,251 | 0.0% | 0.04% | -2.6% |
| Q2 2017 | $6,435,000 | -1.3% | 76,251 | 0.0% | 0.04% | 0.0% |
| Q1 2017 | $6,522,000 | +9.9% | 76,251 | 0.0% | 0.04% | +8.6% |
| Q4 2016 | $5,935,000 | -24.5% | 76,251 | -23.9% | 0.04% | -25.5% |
| Q3 2016 | $7,859,000 | -22.4% | 100,251 | 0.0% | 0.05% | -21.7% |
| Q2 2016 | $10,125,000 | +6.5% | 100,251 | 0.0% | 0.06% | +5.3% |
| Q1 2016 | $9,510,000 | +338.5% | 100,251 | +329.3% | 0.06% | +338.5% |
| Q4 2015 | $2,169,000 | +9.0% | 23,351 | 0.0% | 0.01% | +8.3% |
| Q3 2015 | $1,990,000 | -41.9% | 23,351 | -41.6% | 0.01% | -33.3% |
| Q2 2015 | $3,424,000 | +0.8% | 40,000 | 0.0% | 0.02% | +5.9% |
| Q1 2015 | $3,396,000 | -0.9% | 40,000 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $3,428,000 | +12.8% | 40,000 | 0.0% | 0.02% | +13.3% |
| Q3 2014 | $3,039,000 | -3.5% | 40,000 | 0.0% | 0.02% | -6.2% |
| Q2 2014 | $3,149,000 | +5.0% | 40,000 | 0.0% | 0.02% | 0.0% |
| Q1 2014 | $3,000,000 | -2.8% | 40,000 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $3,088,000 | +11.4% | 40,000 | 0.0% | 0.02% | 0.0% |
| Q3 2013 | $2,773,000 | +9.5% | 40,000 | 0.0% | 0.02% | +6.7% |
| Q2 2013 | $2,532,000 | – | 40,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |